Nothing Special   »   [go: up one dir, main page]

Ramírez-Labrada et al., 2022 - Google Patents

All about (NK cell-mediated) death in two acts and an unexpected encore: initiation, execution and activation of adaptive immunity

Ramírez-Labrada et al., 2022

View HTML
Document ID
16213498671918836463
Author
Ramírez-Labrada A
Pesini C
Santiago L
Hidalgo S
Calvo-Pérez A
Oñate C
Andrés-Tovar A
Garzón-Tituaña M
Uranga-Murillo I
Arias M
Galvez E
Pardo J
Publication year
Publication venue
Frontiers in Immunology

External Links

Snippet

NK cells are key mediators of immune cell-mediated cytotoxicity toward infected and transformed cells, being one of the main executors of cell death in the immune system. NK cells recognize target cells through an array of inhibitory and activating receptors for …
Continue reading at www.frontiersin.org (HTML) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes

Similar Documents

Publication Publication Date Title
Ramírez-Labrada et al. All about (NK cell-mediated) death in two acts and an unexpected encore: initiation, execution and activation of adaptive immunity
Russell et al. Lymphocyte-mediated cytotoxicity
Jing et al. Identification of an ADAM17 cleavage region in human CD16 (FcγRIII) and the engineering of a non-cleavable version of the receptor in NK cells
Zhang et al. CD58 immunobiology at a glance
Feig et al. How apoptosis got the immune system in shape
Chowdhury et al. Death by a thousand cuts: granzyme pathways of programmed cell death
Cohen et al. Apoptosis and programmed cell death in immunity
Hirst et al. The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency
Chavez-Galan et al. Cell death mechanisms induced by cytotoxic lymphocytes
Belizário et al. When and how NK cell-induced programmed cell death benefits immunological protection against intracellular pathogen infection
Haque et al. Utilizing regulatory T cells against rheumatoid arthritis
Cantoni et al. Escape of tumor cells from the NK cell cytotoxic activity
Wang et al. Immunomodulatory role of metalloproteases in cancers: Current progress and future trends
Fischer et al. The Smac mimetic BV6 improves NK cell-mediated killing of rhabdomyosarcoma cells by simultaneously targeting tumor and effector cells
Staniek et al. TRAIL-R1 and TRAIL-R2 mediate TRAIL-dependent apoptosis in activated primary human B lymphocytes
Lettau et al. Intra-and extracellular effector vesicles from human T and NK cells: same-same, but different?
Pang et al. Discordance in STING-induced activation and cell death between mouse and human dendritic cell populations
Qin et al. A novel mechanism of regulatory T cell-mediated down-regulation of autoimmunity
McKenzie et al. Greek fire, poison arrows, and scorpion bombs: how tumor cells defend against the siege weapons of cytotoxic T lymphocytes
Burster et al. Cathepsin G and its dichotomous role in modulating levels of MHC class I molecules
JP2021534785A (en) Methods and Compositions for Adoptive T Cell Therapy Using Induced Notch Signaling
Meng et al. Engineered algae microrobots as photosynthetic living materials promote T cells’ anti-tumor immunity
Ockfen et al. Actin cytoskeleton remodeling at the cancer cell side of the immunological synapse: good, bad, or both?
Zhou Perforin: more than just a pore-forming protein
Cigalotto et al. Granzymes in health and diseases: the good, the bad and the ugly